Vaccination and healthy aging
- PMID: 20192710
- DOI: 10.1586/erv.10.26
Vaccination and healthy aging
Abstract
The aging process in humans is associated with a decrease in immune function (immunosenescence) and an increase in comorbid disorders. When combined with environmental factors this can lead to an increased risk and severity of infectious diseases. Diseases in older adults (>/=70 years) tend to be more severe and have a greater impact on health outcomes such as morbidity, disability, quality of life and mortality. However, some of the more common infections such as influenza and pneumococcal infection are vaccine preventable, but the uptake of such preventive strategies in adults has been poor. In this review some of the key clinical findings supporting the benefits of adult immunization are highlighted. Vaccination of the adult population needs to be a key component of a healthy aging strategy, since there is already convincing evidence that this approach can have an important impact on morbidity, mortality and quality of life.
Similar articles
-
Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.Expert Rev Vaccines. 2009 May;8(5):593-606. doi: 10.1586/erv.09.12. Expert Rev Vaccines. 2009. PMID: 19397416 Review.
-
Age-related decline in immunity: implications for vaccine responsiveness.Expert Rev Vaccines. 2008 May;7(4):467-79. doi: 10.1586/14760584.7.4.467. Expert Rev Vaccines. 2008. PMID: 18444893 Review.
-
Ensuring the willingness to vaccinate and be vaccinated.Expert Rev Vaccines. 2010 Mar;9(3 Suppl):11-4. doi: 10.1586/erv.10.28. Expert Rev Vaccines. 2010. PMID: 20192712 Review.
-
Immunosenescence: Implications for vaccination programmes in adults.Maturitas. 2011 Apr;68(4):322-30. doi: 10.1016/j.maturitas.2011.01.011. Epub 2011 Feb 12. Maturitas. 2011. PMID: 21316879 Review.
-
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.Expert Rev Vaccines. 2010 Mar;9(3 Suppl):15-20. doi: 10.1586/erv.10.29. Expert Rev Vaccines. 2010. PMID: 20192713 Review.
Cited by
-
Promising Expectations for Pneumococcal Vaccination during COVID-19.Vaccines (Basel). 2021 Dec 20;9(12):1507. doi: 10.3390/vaccines9121507. Vaccines (Basel). 2021. PMID: 34960253 Free PMC article. Review.
-
Impact of aging on viral infections.Microbes Infect. 2010 Dec;12(14-15):1120-4. doi: 10.1016/j.micinf.2010.08.009. Epub 2010 Sep 16. Microbes Infect. 2010. PMID: 20849976 Free PMC article. Review.
-
The remaining challenges of pneumococcal disease in adults.Eur Respir Rev. 2012 Mar 1;21(123):57-65. doi: 10.1183/09059180.00008911. Eur Respir Rev. 2012. PMID: 22379175 Free PMC article. Review.
-
Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate".Vaccines (Basel). 2021 Oct 22;9(11):1232. doi: 10.3390/vaccines9111232. Vaccines (Basel). 2021. PMID: 34835163 Free PMC article.
-
The future of immunization policies in Italy and in the European Union: The Declaration of Erice.Hum Vaccin Immunother. 2015;11(5):1268-71. doi: 10.1080/21645515.2015.1019980. Hum Vaccin Immunother. 2015. PMID: 25806425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical